title: A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).
abstract: The purpose of this study was to identify risk factors for the progression of low-grade glioma in children from a large population-based cohort. Patient and tumor details of a national cohort of children with low-grade glioma, recruited into an international multidisciplinary clinical strategy, were subjected to univariate and multivariate analyses of progression-free survival and overall survival. From the cohort of 798 patients, 639 patients were eligible, with a median age 6.71 years (0.26-16.75 years); 49% were males; 15.9% had neurofibromatosis type 1, 63.7% pilocytic astrocytoma, 5.9% fibrillary astrocytoma, 4.2% mixed neuronal-glial tumors, and 3.6% others; 21.1% were diagnosed clinically. Anatomically implicated were 31.6% cerebellum, 24.6% chiasma/hypothalamus, 16.0% cerebral hemispheres, 9.9% brain stem, 6.1% other supratentorial midline structures, 5.9% optic nerve only, 4.5% spinal cord, and 1.4% others. The 5-year overall survival and progression-free survival in the whole cohort were 94.6% and 69.4%, respectively. There was a significant association between age and site (P < .001) and extent of tumor resection and site (P < .001). Multivariate analysis identified young age, fibrillary astrocytoma, and extent of surgical resection as significant independent risk factors for progression. Hypothalamic/chiasmatic tumors demonstrated the most sustained tendency to progress. In conclusion, the influence of age and anatomical site upon the risk of tumor progression suggests that these factors strongly influence tumor behavior for the majority of pilocytic tumors. Age <1 year and 1-5 years, fibrillary histology, completeness of resection, and chiasmatic location are candidates for stratification in future studies.
authors.affiliation: Children's Brain Tumour Research Centre, Division of Human Development, Queen's Medical Centre, University of Nottingham, Nottingham.
authors.forename: Tore
authors.initials: T
authors.lastname: Stokland
authors.forename: Jo-Fen
authors.initials: JF
authors.lastname: Liu
authors.forename: James W
authors.initials: JW
authors.lastname: Ironside
authors.forename: David W
authors.initials: DW
authors.lastname: Ellison
authors.forename: Roger
authors.initials: R
authors.lastname: Taylor
authors.forename: Kathryn J
authors.initials: KJ
authors.lastname: Robinson
authors.forename: Susan V
authors.initials: SV
authors.lastname: Picton
authors.forename: David A
authors.initials: DA
authors.lastname: Walker
mesh_terms: D000293:Adolescent; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D018450:Disease Progression; D005260:Female; D005910:Glioma / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D007223:Infant; D008297:Male; D010865:Pilot Projects; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate